Thermo Fisher announces new suite of assays

By The Science Advisory Board staff writers

July 19, 2021 -- Thermo Fisher Scientific announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T cells and B cells.

The company said the assays target multiple parts of the B- and T-cell immune receptors using a single reaction with ultrahigh sensitivity, increasing the probability of malignant clone detection and decreasing the time to results.

The suite is available on Thermo Fisher's Ion GeneStudio S5 system and features integrated analysis and data visualization tools for laboratories and healthcare professionals.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here